Chronic Gastritis Clinical Trial
Official title:
Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases: A Prospective Self-controlled Comparative Multicenter Trial
A new Magnetic-controlled Capsule Endoscopy (MCE) was developed by ANKON and got SFDA's approval in China in 2013. It has recently been evaluated to compare the diagnostic accuracy of MCE with that of standard gastroscopy for gastric diseases in 70 patients with encouraging results (In Press). To further testify the diagnostic accuracy of MCE for both the diffuse and focal diseases in stomach, we performed this single-blinded multi-center prospective study compared MCE with gastroscopy in patients with gastric symptoms and indication for upper GI Endoscopy.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04066530 -
A Study to Evaluate the Efficacy and Safety of AD-203
|
Phase 3 | |
| Recruiting |
NCT05048069 -
Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.
|
||
| Completed |
NCT01817556 -
A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.
|
Phase 4 | |
| Recruiting |
NCT01813812 -
A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034
|
Phase 3 | |
| Completed |
NCT00996788 -
Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis
|
Phase 3 | |
| Completed |
NCT04341454 -
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis
|
Phase 3 | |
| Enrolling by invitation |
NCT05021029 -
A Study of Pre-Malignant Gastric Conditions
|
||
| Completed |
NCT05073614 -
Evaluation of Immunohistochemical Expression of Heparanase in Helicobacter Pylori-Associated Chronic Gastritis
|
N/A | |
| Completed |
NCT04697186 -
Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy
|
Phase 4 | |
| Recruiting |
NCT00455806 -
Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection
|
Phase 3 | |
| Recruiting |
NCT05666531 -
Research on Innovative Diagnosis and Treatment System of Syndrome Differentiation of Zang-fu Viscera and Effectiveness Evaluation Based on Inter-Arm Blood Pressure Measured Simultaneously
|
||
| Completed |
NCT03847753 -
Exploring the Comorbidity Between Mental Disorders and General Medical Conditions
|
||
| Completed |
NCT04189705 -
A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis
|
Phase 3 | |
| Completed |
NCT05014334 -
Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication
|
Phase 4 | |
| Completed |
NCT02356679 -
Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients
|
Phase 4 | |
| Completed |
NCT03609892 -
Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy
|
Phase 4 | |
| Unknown status |
NCT02282670 -
A Study to Evaluate the Efficacy and Safety of DA-5204
|
Phase 3 | |
| Completed |
NCT01119768 -
Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients
|
Phase 4 | |
| Completed |
NCT02658864 -
Pharmacokinetic Properties and Effect of Food on Pharmacokinetic Properties of the Oral Lafutidine Tablets
|
Phase 1 |